Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
3 of the patients were already entering the BLIND ZONE. They were in dire straits and would try anything to help restore and repair their vision. So I disagree with your overblown statement
Outstanding Shares 375,895,326 3/05/2019 +34,296,830
Restricted 64,400,549 03/05/2019 (0)
Unrestricted 311,494,777 03/05/2019 +44,393,349
Held at DTC 311,426,777 03/05/2019 +44,325,777
$SPDL
$CLSK consolidating in the low $4's..
$SPDL $0.0007 -0.0003 (-30.00%) Volume 9,267,608 (Average)
$BTCY $0.75 -0.075 (-9.09%) Volume 22,204 Volume(Below Average)
22,204
Accumulation has picked up in the last 5 weeks. $USRM
Unrestricted shares 312,991,740 03/04/2019
Dr. Elias Said, MD FACEP, Regenerative Medical Health, Los Cruces on CaverStem
Side Effects of CaverStem™ Erectile Dysfunction Procedure (0)
https://www.caverstem.com/no-side-effects-caverstem
7 Benefits of CaverStem™ Procedure For ED
https://www.caverstem.com/permanent-solution-caverstem
USING STEM CELLS TO TREAT HIV
https://www.yahoo.com/news/london-patient-second-case-ever-hiv-remission-044208642.html
Axsome to host conference call and webcast on Thursday, March 14, 2019 at 8:00 AM Eastern Time
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will report its financial results for fiscal year 2018 on Thursday, March 14, 2019 before the opening of the U.S. financial markets. Axsome’s management team will host a conference call at 8:00 AM Eastern Time on March 14, 2019 to discuss these results and provide a business update.
To participate in the live conference call, please dial (844) 698-4029 (toll-free domestic) or (647) 253-8660 (international) and use the conference ID 9087075. A live webcast of the conference call can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at www.axsome.com. A recording of the conference call will be available on the Company’s website for approximately 30 days following the live event.
https://ih.advfn.com/stock-market/NASDAQ/axsome-therapeutics-inc-AXSM/stock-news/79401316/axsome-therapeutics-to-report-fourth-quarter-and-f
U.S. Stem Cell Clinic
https://usstemcellclinic.com/
Outstanding Shares 386,675,905 03/04/2019
Restricted 73,684,165 03/04/2019
Unrestricted 312,991,740 03/04/2019
Market Cap 24,854,920 3/1/2019.. $BTCY
Unrestricted shares 12,621,035 as of 3/1/19.. $BTCY
OS 30,589,440 as of 3/1/19.. + 462,264.. $BTCY
$SPDL $0.0008 -0.0001 (-11.11%) Volume 886,000
$BTCY list of accomplishments and upcoming milestones:
•Bioflux was named Best Remote Patient Monitoring Solution by MedTech Breakthrough on June 6, 2018
•Direct sales representatives are positioned in six states across the country with plans to expand the current sales force.
•Reimbursement by private payers and MEDICARE for the Bioflux solution is progressing successfully without any reported issues.
•The company will continue to build out infrastructure and operations to support expansion and growth.
•Prepare for FDA filing of Biopatch, an ECG patch which offers an alternative to the 3-lead system for patients with less complicated cardiac conditions, in early 2019 to garner incremental revenue and expand the company’s product portfolio.
7 Types Of Medications That Cause Erectile Dysfunction
Achieving an erection requires the coordination and proper functioning of several organs. Your brain should be sending the right signals to your penis. Your nerves should be able to receive those signals properly. Your blood vessels should be healthy. You should have sufficient testosterone. And you should have the right balance of chemicals in your body.
When any of these elements are not working properly, such as when there’s a chemical imbalance in your brain, it could interfere with your body’s ability to achieve and maintain erections. Unfortunately, there are times when medications that you need to take for other conditions can mess up your erectile function.
#1 CHEMOTHERAPY DRUGS
The importance of chemotherapy drugs to cancer patients is undeniable. However, when one of the side effects is something as severe and psychologically impacting as erectile dysfunction, healthcare providers should have an in-depth discussion with the patient to set proper expectations and provide options. Male cancer patients should be informed that chemotherapy drugs often cause erectile dysfunction, and in some cases, permanent infertility.
#2 ANTIHYPERTENSIVE DRUGS
Male hypertensive patients often also exhibit erectile dysfunction. This is because chronic blood pressure elevation causes functional as well as structural changes in the arteries of the penis, reducing the ability of the penile arteries to deliver sufficient penile blood flow to support an erection.
Unfortunately, certain antihypertensive medications contribute to the prevalence of erectile dysfunction in patients suffering from high blood pressure. Not all antihypertensive drugs have negative effects on erectile function. This adverse side effect is associated with older-generation antihypertensive medications.
Diuretics, central acting, and beta-blocker medications are the ones linked to erectile dysfunction. For instance, chlorthalidone, a diuretic drug, is associated with incidences of erectile dysfunction. Newer-generation antihypertensive drugs, however, are considered to have either neutral or beneficial effects on sexual function.
#3 ANTIEPILEPTIC DRUGS
Epileptic men have higher risks of developing erectile dysfunction. Reduced libido and impaired sexual performance are often reported by adult male epileptic patients. Previous studies have also found that those who had temporal lobe epilepsy were more likely to develop hypogonadism and sexual abnormalities as compared to those who had primary generalized epilepsy.
To add to the problem, antiepileptic medications affect sex hormones concentrations and the regulatory mechanisms of endocrine glands. This adds to the sexual dysfunction issues epileptic patients encounter.
#4 ANTIHISTAMINES
You may not know it but that medicine you’re taking for your allergies may actually be damaging your erectile functions. Antihistamines are known to reduce the volume of blood flowing to the penis. And when there’s not enough penile blood flow, erections won’t happen.
More than twenty years ago, researchers already found out that histamine plays a role in human erectile processes. In a 1995 study, scientists tried injecting 30 micrograms of histamine into the penis of male patients.
Thirteen percent of the men achieved full erections after the injection while the rest had partial erections. When they doubled the dose, 26% of the male patients achieved erections. Years later, the beneficial effects of histamine on human penile erections were validated in other studies.
Antihistamine medications, however, prevent the actions of histamine. Antihistamines are definitely beneficial when you’re suffering from allergies, but they do cause temporary erectile dysfunction.
#5 ANTI-PARKINSON’S DISEASE MEDICATIONS
The brain plays an important part in proper sexual functioning and since Parkinson’s disease causes degenerative damage to the brain, patients with Parkinson’s consequently suffer sexual dysfunction.
Female Parkinson’s disease patients often suffer from reduced libido and decreased sexual satisfaction. In men, sexual dysfunction occurs as erectile dysfunction, ejaculatory disorders, and sexual dissatisfaction.
Acetylcholine is a neurotransmitter that plays a role in the regulation of erections. Anticholinergic medications interfere with the actions of acetylcholine and thus prevent erections.
Some of the common medications for Parkinson’s disease are classified as anticholinergic drugs and these include benztropine and trihexyphenidyl. Both block acetylcholine to decrease muscle stiffness and prevent muscle spasms in patients with Parkinson’s disease.
#6 PROSTATE CANCER MEDICATIONS
man with blue ribbon for prostate cancer awarenessTestosterone aids in the spread of prostate cancer cells. Thus, many prostate cancer medications block testosterone to slow down the spread and growth of the cancerous cells. Flutamide is one of the commonly prescribed prostate cancer medications that block testosterone. Bicalutamide and nilutamide are also used as androgen blockers.
Androgen deprivation therapy (ADT) is a common form of treatment for prostate cancer patients. Unfortunately, due to the nature of the disease and the nature of the medications used to treat the condition, ADT almost always results in erectile dysfunction.
For one, androgen deprivation therapy directly affects the smooth muscle structures in the penis, thereby decreasing penile erection. Moreover, androgens like testosterone help protect the neurological structures in the penis. When a prostate cancer patient is treated with anti-androgens, they lose this protection.
#7 ANTIDEPRESSANT MEDICATIONS
Antidepressant medications usually work by tweaking the balance of chemicals and neurotransmitters in the brain. For instance, selective serotonin reuptake inhibitors (SSRIs) work on serotonin which is a neurotransmitter that helps regulate mood. Serotonin is also involved in the regulation of sexual desire as well as in the performance of sexual functions.
antidepressant medication can cause erectile dysfunctionSSRIs basically stop serotonin from being deactivated or reabsorbed into the body. Thus, serotonin levels remain high, which is supposed to help improve the mood of depressed people but has the unfortunate effect of inhibiting sexual activity.
Of the various SSRIs available today, paroxetine is considered as the one most associated with erectile dysfunction. Other types of SSRIs such as sertraline and fluoxetine are also associated with sexual dysfunction.
For patients suffering from depression who don’t want their erectile functions to be affected, specialists recommend bupropion, an antidepressant medication that works through a different mechanism.
Other medications that also affect sexual function include antipsychotic drugs and anti-mania medications. Prevalence of erectile dysfunction in patients taking antipsychotic medications is as high as 40% or more.
Antipsychotic drugs work interfere with the functions of dopamine, histamine, and acetylcholine, which are all important for proper erectile function. Medications that block the receptors for dopamine decreases libido and hinders with a man’s capacity for arousal and orgasm.
https://webmdmen.com/7-types-of-medications-that-cause-erectile-dysfunction/
A very detailed and informative post. Thank you
Outstanding Shares 991,150,917 03/01/2019
Will $CELZ be presenting Femcelz at the AUA May 03-06 in Chicago so they can get it ready for commercialization?
Could $BTCY be bought out..? Market cap $24,403,013.. Looks attractive..
CleanSpark was added to the LD Micro index last month.
https://www.marketwatch.com/press-release/cleanspark-included-in-ld-micro-index-rebalance-2019-02-11
DOW listing requirements
https://www.goodfinancialcents.com/how-to-be-listed-on-dow-jones-industrial-average/
NASDAQ listing requirements
https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/
Hello Sir.. I been doing the DD and $CELZ has made a lot of progress in the last several months. They also expect revenues to increase each quarter as they get ready to commercialize Femcelz.. You've made some progress also and I look forward to your expert commentary.. Congrats..
7 Benefits of CaverStem™ Procedure For ED
https://www.caverstem.com/locations-caverstem
The move to get patients out of doctors offices and hospitals quickly using virtual care and remote monitoring is underway. Technology is enabling the switch, and few subsectors have benefitted more than remote cardiac care. Companies like Biotelemetry (BEAT) have grown by leaps and bounds in the last few years as their proprietary remote cardiac monitoring devices have gained traction. They're doing $400M in annual sales, and their stock has climbed from trough lows at $2.50 in 2013 to $65 in just 5 years.
•Biotricity ($BTCY) is a small monitoring company with an attractive valuation compared to its bigger peers, entering the market just after their first FDA clearance. The stock is near 52-week lows after post-approval blues and could be rebounding in 2019 as this product launch goes full steam. It doesn't take much to demonstrate traction with a great device in this huge market, and with the right execution and sales figures coming, $BTCY could look like BEAT at $2.50 five years ago.
Unfortunately those #'s will change when the latest round of DILUTION is REPORTED .. $SPDL
Axsome if they care: Trials by Grunenthal launching IP war in daunting CRPS zone
http://www.bioworld.com/content/axsome-if-they-care-trials-grunenthal-launching-ip-war-daunting-crps-zone
and is on track to announce topline results in early January 2019, as previously disclosed. It's March 1st, no news yet.
$CLSK $3.91 -0.69
Paid PROMO out.. $CLSK
https://ih.advfn.com/stock-market/USOTC/cleanspark-inc-CLSK/stock-news/79372574/microgrid-companies-on-the-rise
Legal Disclaimer:
This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with CLSK dated 9/12/18. The agreement calls for $10,000 in cash, and 30,000 restricted 144 shares of CLSK per month. Regal and CLSK have signed an amendment to extend the contract for twelve months starting 10/10/18, and increased the cash component to $20,000 per month. CLSK has paid an additional $12,000 for services provided in November. CLSK has paid an additional $88,000 for services provided in December. CLSK has paid an additional $100,000 for services for January. CLSK has paid an additional $80,000 for services for February.
$BTCY $0.81
Market Cap 25,005,556.. $BTCY CEO Waqaas Al-Siddiq moving shareholders to the toilet.. Courtesy flush
$SFAD x-BOD Michael Kelly's resignation letter from last year.
January 26, 2018
Spindle Board of Directors
1201 S. Alma School Rd., Suite 12500
Mesa, AZ 85210
Re: Resignation as Board Member
Dear Board,
Please accept this as my immediate resignation from Spindle's Board of Directors (the "Board"). My resignation from the Board is due to the following activities of Spindle's management:
·Misrepresenting to the board of material facts regarding acquisition targets;
·Committing Spindle to transactions in which Spindle's performance is wholly impractical due to fiscal challenges;
·Providing the Board with misleading forecasts and memorandum;
·Entering into agreements, financing agreements, accepting undocumented loans, without consent of the board;
·Signing resolutions of the Board without Board consent; and
·Generally precluding my fulfillment of my fiduciary duties as a member of the Board.
I hope you work to correct these problems as soon as possible to provide value to Spindle's shareholders.
Sincerely,
/s/ Michael Kelly
Michael Kelly
https://ir.spindle.com/sec-filings-email/content/0001393905-18-000031/spdl_ex102.htm
$BTCY went silent. The dilution should almost be over.
$SPDL is a Shell Risk per the OTC
https://www.otcmarkets.com/stock/SPDL/security
The Shell Risk designation indicates that a company displays characteristics common to Shell Companies. This designation is made at OTC Markets’ sole and absolute discretion based on an analysis of the company’s annual financial data and may differ from issuers’ self-reported shell classifications in their own public filings.
Yesterdays volume 115.0 million.. More Dilution..
FYI.. The Form 4 mentioned in this forum is not $SPDL.. It is SFDL (SECURITY FEDERAL CORP)
https://www.sec.gov/Archives/edgar/data/818677/000093905719000084/xslF345X03/primary_doc.xml